Israel-based HealthTech VC aMoon leads this $11 million financing round, backed by 83North, Dell Technologies Capital and existing investor Kamet Ventures (Axa’s venture arm).
Ibex will use the funds to go through the development of its solution for other pathologies and start international expansion.
First deal closed by Clipperton in Israel.